Weijing Yang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
Papers in
- Biomaterials 25
- Nanoparticle-Based Drug Delivery 25
- Immunology 22
- Immune cells in cancer 9
- Immunotherapy and Immune Responses 8
- Co-authors
- Zhiyuan Zhong (18 shared papers)Hongzhang Deng (12 shared papers)Lisen Lin (10 shared papers)Fenghua Meng (17 shared papers)Xiaoyuan Shawn Chen (9 shared papers)Sheng Wang (9 shared papers)Zijian Zhou (10 shared papers)Guocan Yu (8 shared papers)
- Journals
- Journal of Controlled Release (10 papers)Nature Communications (5 papers)Advanced Materials (5 papers)ACS Nano (4 papers)Nano Today (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Weijing Yang
68 papers receiving 4.4k citations
Weijing Yang's Hit Papers
Peers
Comparison fields: 5 of 119
- Biomaterials 1.4k
- Biomedical Engineering 2.7k
- Immunology 808
- Materials Chemistry 1.1k
- Molecular Biology 1.5k
Countries citing papers authored by Weijing Yang
This map shows the geographic impact of Weijing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijing Yang more than expected).
Fields of papers citing papers by Weijing Yang
This network shows the impact of papers produced by Weijing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijing Yang. The network helps show where Weijing Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weijing Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy Hit paper breakdown → | 2020 | 333 |
| 2 | 2019 | 319 | |
| 3 | 2020 | 254 | |
| 4 | 2020 | 236 | |
| 5 | 2019 | 226 | |
| 6 | 2020 | 216 | |
| 7 | 2019 | 215 | |
| 8 | 2019 | 169 | |
| 9 | 2017 | 150 | |
| 10 | 2019 | 146 | |
| 11 | 2018 | 145 | |
| 12 | 2022 | 132 | |
| 13 | 2013 | 113 | |
| 14 | 2021 | 110 | |
| 15 | 2014 | 87 | |
| 16 | 2014 | 85 | |
| 17 | 2020 | 85 | |
| 18 | 2020 | 82 | |
| 19 | 2014 | 78 | |
| 20 | 2015 | 74 |
About Weijing Yang
Weijing Yang is a scholar working on Biomaterials, Immunology, Biomedical Engineering, Oncology and Molecular Biology, having authored 69 papers that have together received 4.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (31 papers), Nanoparticle-Based Drug Delivery (25 papers), RNA Interference and Gene Delivery (14 papers), Immune cells in cancer (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Photodynamic Therapy Research Studies (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). The work is most often cited by research in Biomaterials (1.4k citations), Biomedical Engineering (2.7k citations), Immunology (808 citations), Materials Chemistry (1.1k citations) and Molecular Biology (1.5k citations). Weijing Yang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Zhiyuan Zhong, Hongzhang Deng, Lisen Lin, Fenghua Meng, Xiaoyuan Shawn Chen, Sheng Wang, Zijian Zhou, Guocan Yu, Rui Tian and Jibin Song. Their work appears in journals such as Journal of Controlled Release, Nature Communications, Advanced Materials, ACS Nano and Nano Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.